Vimizim® (elosulfase alfa)
| Full Name | Vimizim® (elosulfase alfa) |
| Drug | Vimizim |
| Manufacturer | BioMarin Pharmaceutical Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome) |
| Disease | Mucopolysaccharidosis IVA |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Vimizim Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | vimizim.com |
| Patient Resources | National MPS Society |